Travere Therapeutics, Inc. (TVTX)
$65.49-$2.03 (-3.01%) Today
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 7 | 24,500 | $1.36M |
| Option exercise | 8 | 49,000 | |
| Bona-fide gift | 1 | 468 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
69 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Elizabeth E. Reed - Officer | Option exercise | Common Stock | 10,000 | $19.08 | $191K | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 20,000 | $17.96 | $359K | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 7,500 | $15.46 | $116K | |
| Elizabeth E. Reed - Officer | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 37,500 | $41.07 | $1.54M | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 7,215 | $41.93 | $303K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 5,226 | $41.62 | $218K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 1,559 | $42.53 | $66K | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 7,500 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 10,000 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Christopher R. Cline - Officer | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 65 | $28.85 | $2K | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 9 | $41.07 | $370 | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 7,239 | $41.93 | $304K | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 1,014 | $42.61 | $43K | |
 Jula Inrig - Officer | Grant or award | Common Stock | 14,000 | $0.00 | - | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 7,215 | $41.93 | $303K | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 1,018 | $42.61 | $43K | |
| Roy D. Baynes | Option exercise | Common Stock | 10,000 | $26.52 | $265K | |
| Roy D. Baynes | Open-market sale | Common Stock | 10,000 | $33.00 | $330K | |
| Roy D. Baynes | Option exercise | Stock option (right to buy) | 10,000 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 60,000 | $15.46 | $928K | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 34,902 | $30.55 | $1.07M | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 25,098 | $31.46 | $790K | |
| Eric M. Dube - Officer | Option exercise | Employee stock option (right to buy) | 60,000 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 10,000 | $15.46 | $155K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 10,000 | $30.00 | $300K | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 10,000 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 10,000 | $19.08 | $191K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 10,000 | $28.09 | $281K | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 10,000 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 60,000 | $15.46 | $928K | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 60,000 | $30.10 | $1.81M | |
| Eric M. Dube - Officer | Option exercise | Employee stock option (right to buy) | 60,000 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 10,000 | $19.08 | $191K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 5,679 | $27.50 | $156K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 4,321 | $28.26 | $122K | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 10,000 | $0.00 | - | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 1,547 | $32.11 | $50K | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 232 | $32.85 | $8K | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 1,635 | $32.14 | $53K | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 110 | $32.90 | $4K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 2,485 | $32.07 | $80K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 509 | $32.74 | $17K | |
| Eric M. Dube - Officer | Grant or award | Common Stock | 113,800 | $0.00 | - | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 66,452 | $32.06 | $2.13M | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 33,635 | $32.70 | $1.10M | |
| Eric M. Dube - Officer | Grant or award | Employee stock option (right to buy) | 303,600 | $0.00 | - | |
| Jula Inrig - Officer | Grant or award | Common Stock | 28,130 | $0.00 | - | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 6,956 | $32.12 | $223K | |
| Jula Inrig - Officer | Grant or award | Employee stock option (right to buy) | 75,000 | $0.00 | - | |
| Christopher R. Cline - Officer | Grant or award | Common Stock | 28,130 | $0.00 | - | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 7,242 | $32.12 | $233K | |
| Christopher R. Cline - Officer | Grant or award | Employee stock option (right to buy) | 75,000 | $0.00 | - | |
 Peter Heerma - Officer | Grant or award | Common Stock | 26,120 | $0.00 | - | |
| Peter Heerma - Officer | Open-market sale | Common Stock | 7,310 | $32.12 | $235K | |
| Peter Heerma - Officer | Grant or award | Employee stock option (right to buy) | 69,640 | $0.00 | - | |
| William E. Rote - Officer | Grant or award | Common Stock | 20,090 | $0.00 | - | |
| William E. Rote - Officer | Open-market sale | Common Stock | 12,446 | $32.87 | $409K | |
| William E. Rote - Officer | Grant or award | Employee stock option (right to buy) | 53,570 | $0.00 | - | |
| Sandra Calvin - Officer | Grant or award | Common Stock | 15,180 | $0.00 | - | |
| Sandra Calvin - Officer | Open-market sale | Common Stock | 4,333 | $32.12 | $139K | |
| Sandra Calvin - Officer | Grant or award | Employee stock option (right to buy) | 20,160 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Grant or award | Common Stock | 25,110 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 7,175 | $32.12 | $230K | |
| Elizabeth E. Reed - Officer | Grant or award | Employee stock option (right to buy) | 66,960 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 8,135 | $15.46 | $126K | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 51,865 | $15.46 | $802K | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 8,135 | $30.01 | $244K | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 51,865 | $30.10 | $1.56M | |
| Eric M. Dube - Officer | Option exercise | Employee stock option (right to buy) | 8,135 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Employee stock option (right to buy) | 51,865 | $0.00 | - | |
| Elizabeth E. Reed - Officer | Option exercise | Common Stock | 10,000 | $19.08 | $191K | |
| Elizabeth E. Reed - Officer | Open-market sale | Common Stock | 10,000 | $27.34 | $273K | |
| Elizabeth E. Reed - Officer | Option exercise | Employee stock option (right to buy) | 10,000 | $0.00 | - | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 2,031 | $40.18 | $82K | |
| Jula Inrig - Officer | Open-market sale | Common Stock | 445 | $37.75 | $17K | |
| Sandra Calvin - Officer | Open-market sale | Common Stock | 2,910 | $36.00 | $105K | |
| Christopher R. Cline - Officer | Option exercise | Common Stock | 20,000 | $16.23 | $325K | |
| Christopher R. Cline - Officer | Open-market sale | Common Stock | 20,000 | $35.01 | $700K | |
| Christopher R. Cline - Officer | Option exercise | Employee stock option (right to buy) | 20,000 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 10,000 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 17,500 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 15,000 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 12,500 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Employee stock option (right to buy) | 6,250 | $0.00 | - | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 10,000 | $25.25 | $253K | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 17,500 | $26.88 | $470K | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 15,000 | $27.50 | $413K | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 12,500 | $22.40 | $280K | |
| Sandra Calvin - Officer | Option exercise | Common Stock | 6,250 | $8.93 | $56K | |
| Sandra Calvin - Officer | Open-market sale | Common Stock | 67,115 | $36.00 | $2.42M | |
| Timothy Coughlin | Option exercise | Director stock option (right to buy) | 10,000 | $0.00 | - | |
| Timothy Coughlin | Option exercise | Common Stock | 8,000 | $16.33 | $131K | |
| Timothy Coughlin | Option exercise | Common Stock | 10,000 | $17.44 | $174K | |
| Timothy Coughlin | Open-market sale | Common Stock | 18,000 | $35.03 | $631K | |
| Timothy Coughlin | Option exercise | Director stock option (right to buy) | 8,000 | $0.00 | - | |
| Peter Heerma - Officer | Open-market sale | Common Stock | 5,591 | $35.00 | $196K | |
| Peter Heerma - Officer | Gift | Common Stock | 1,078 | $0.00 | - | |
| Peter Heerma - Officer | Open-market sale | Common Stock | 2,662 | $30.00 | $80K | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 92,872 | $15.46 | $1.44M | |
| Eric M. Dube - Officer | Option exercise | Common Stock | 27,128 | $15.46 | $419K | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 92,872 | $30.38 | $2.82M | |
| Eric M. Dube - Officer | Open-market sale | Common Stock | 27,128 | $30.12 | $817K | |
| Eric M. Dube - Officer | Option exercise | Employee stock option (right to buy) | 92,872 | $0.00 | - | |
| Eric M. Dube - Officer | Option exercise | Employee stock option (right to buy) | 27,128 | $0.00 | - | |
| Peter Heerma - Officer | Gift | Common Stock | 891 | $0.00 | - |
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GARY LYONS | Director | 5,000 | $318K | View on EDGAR | |
| GARY A LYONS | Director | 5,000 | $311K | View on EDGAR | |
| - | - | - | - | View on EDGAR |
Travere Therapeutics, Inc. (TVTX) had 4 insider filings in the last 90 days, with the most recent on 2026-08-19. The full record for TVTX runs to 69 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of TVTX were filed in the last 90 days.
7 insider sales of TVTX were filed in the last 90 days, totaling $1.36M.
This page tracks TVTX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add TVTX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
